$NTRP
NextTrip, Inc. Stock $ntrp

$ntrp Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222021416 Filed on August 05, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$188.2K	$236.7K	$51.84K
YoY Change	-73.12%	64.18%	-88.68%
Cost Of Revenue	$79.71K	$193.1K	$40.09K
YoY Change	-51.62%	65.88%	-68.76%
Gross Profit	$108.5K	$43.59K	$11.75K
YoY Change	-79.73%	57.06%	-96.44%
Gross Profit Margin	57.65%	18.42%	22.67%
Selling, General & Admin	$1.940M	$1.800M	$1.880M
YoY Change	-16.23%	20.21%	45.75%
% of Gross Profit	1787.23%	4130.76%	15998.55%
Research & Development	$152.2K	$146.9K	$143.4K
YoY Change	15.54%	-47.67%	-26.95%
% of Gross Profit	140.28%	337.01%	1220.6%
Depreciation & Amortization	$26.86K	$29.86K	$31.58K
YoY Change	-3.01%	15.82%	37.13%
% of Gross Profit	24.75%	68.51%	268.77%
Operating Expenses	$2.393M	$2.279M	$2.296M
YoY Change	-20.94%	5.11%	28.87%
Operating Profit	-$2.284M	-$2.236M	-$2.284M
YoY Change	-8.31%	4.43%	57.34%
Interest Expense	$1.978K	$2.070K	-$80.00
YoY Change	349.55%	2.02%	-100.01%
% of Operating Profit
Other Income/Expense, Net	-$7.884K	-$11.33K	$76.63K
YoY Change		-103.84%
Pretax Income	-$2.292M	-$2.247M	-$2.207M
YoY Change	-7.98%	21.76%	239.26%
Income Tax
% Of Pretax Income
Net Earnings	-$2.292M	-$2.247M	-$2.207M
YoY Change	-7.98%	21.76%	239.26%
Net Earnings / Revenue	-1217.73%	-949.54%	-4258.1%
Basic Earnings Per Share	-$0.22	-$0.22	-$0.21
Diluted Earnings Per Share	-$218.3K	-$214.0K	-$210.3K
COMMON SHARES
Basic Shares Outstanding	10.50M shares	10.50M shares	10.50M shares
Diluted Shares Outstanding	524.9K shares	10.50M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.801M	$6.934M	$9.278M
YoY Change	-63.25%	-52.93%	-44.92%
Cash & Equivalents	$4.801M	$6.933M	$9.278M
Short-Term Investments
Other Short-Term Assets	$177.7K	$131.5K	$165.3K
YoY Change	36.0%	-21.89%	22.02%
Inventory	$967.4K	$783.7K	$782.1K
Prepaid Expenses	$177.7K	$131.5K
Receivables	$367.8K	$291.8K	$261.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.314M	$8.140M	$10.49M
YoY Change	-57.1%	-49.55%	-42.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$244.8K	$265.7K	$288.9K
YoY Change	21.36%	68.7%	125.16%
Goodwill
YoY Change
Intangibles	$1.084M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.329M	$1.295M	$1.268M
YoY Change	24.21%	36.18%	38.31%
TOTAL ASSETS
Total Short-Term Assets	$6.314M	$8.140M	$10.49M
Total Long-Term Assets	$1.329M	$1.295M	$1.268M
Total Assets	$7.643M	$9.435M	$11.75M
YoY Change	-51.59%	-44.78%	-38.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$403.5K	$240.4K	$320.6K
YoY Change	80.83%	-23.87%	14.3%
Accrued Expenses	$287.6K	$253.8K	$416.6K
YoY Change	-33.51%	37.83%	91.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$820.9K	$624.9K	$897.5K
YoY Change	10.74%	10.9%	-83.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$820.9K	$624.9K	$897.5K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$820.9K	$624.9K	$897.5K
YoY Change	-5.92%	-10.05%	-84.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$47.38M	-$45.08M
YoY Change
Common Stock	$10.50K	$10.50K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.822M	$8.811M	$10.86M
YoY Change
Total Liabilities & Shareholders Equity	$7.643M	$9.435M	$11.75M
YoY Change	-51.59%	-44.78%	-38.24%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.292M	-$2.247M	-$2.207M
YoY Change	-7.98%	21.76%	239.26%
Depreciation, Depletion And Amortization	$26.86K	$29.86K	$31.58K
YoY Change	-3.01%	15.82%	37.13%
Cash From Operating Activities	-$2.072M	-$2.287M	-$2.027M
YoY Change	36.31%	12.9%	63.39%
INVESTING ACTIVITIES
Capital Expenditures	-$60.90K	-$56.95K	-$142.1K
YoY Change	-58.5%	-33.82%	546.79%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$60.90K	-$56.95K	-$142.1K
YoY Change	-58.5%	-33.82%	546.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-2.072M	-2.287M	-2.027M
Cash From Investing Activities	-60.90K	-56.95K	-142.1K
Cash From Financing Activities	0.000	0.000
Net Change In Cash	-2.133M	-2.344M	$0.00
YoY Change	27.97%	11.0%	-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$2.072M	-$2.287M	-$2.027M
Capital Expenditures	-$60.90K	-$56.95K	-$142.1K
Free Cash Flow	-$2.011M	-$2.231M	-$1.885M
YoY Change	46.45%	14.98%	54.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	SGLB	State Incentives StateIncentives		usd
CY2021Q2	SGLB	State Incentives StateIncentives		usd
	SGLB	State Incentives StateIncentives		usd
CY2022Q2	SGLB	Stock Issued During Period Value Dividends Preferred Stock Value StockIssuedDuringPeriodValueDividendsPreferredStockValue		usd
CY2021Q2	SGLB	Stock Issued During Period Value Dividends Preferred Stock Value StockIssuedDuringPeriodValueDividendsPreferredStockValue		usd
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	87507
	SGLB	Stock Issued During Period Value Dividends Preferred Stock Value StockIssuedDuringPeriodValueDividendsPreferredStockValue		usd
	SGLB	Stock Issued During Period Value Dividends Preferred Stock Value StockIssuedDuringPeriodValueDividendsPreferredStockValue		usd
	dei	City Area Code CityAreaCode	(505)
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants		usd
CY2022Q2	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative		usd
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000788611
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo		usd
CY2022Q2	SGLB	Lessee Operating Lease Liability Payments Due Year Threeand Thereafter LesseeOperatingLeaseLiabilityPaymentsDueYearThreeandThereafter		usd
CY2021	SGLB	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Cancelled In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue		usd
	SGLB	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
	SGLB	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Cancelled In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue		usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2021	SGLB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Weighted Average Exercise Price Warrants Forfeited Or Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	SGLB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q2	us-gaap	Assets Current AssetsCurrent	8140398	usd
	dei	Local Phone Number LocalPhoneNumber	438-2576
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	412192	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	783666	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	710080	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	12683597	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	265678	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	232282	usd
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1029315	usd
	dei	Trading Symbol TradingSymbol	SASI
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	925111	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1294993	usd
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1157393	usd
CY2022Q2	us-gaap	Assets Assets	9435391	usd
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	SGLB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q4	us-gaap	Assets Assets	13840990	usd
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11447047	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	291758	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	240400	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	206442	usd
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38015
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Registrant Name EntityRegistrantName	SIGMA LABS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1865814
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3900 Paseo del Sol
	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Fe
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NM
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10498802	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6933499	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	10499	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10499	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53876218	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53442431	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	131475	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	114278	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	130704	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	148855	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	253754	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	625942	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	624858	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	981239	usd
CY2022Q2	us-gaap	Liabilities Liabilities	624858	usd
CY2021Q4	us-gaap	Liabilities Liabilities	981239	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10498802	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10498802	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10498802	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10498802	shares
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1832520	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	167439	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	116441	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45076185	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	193075	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	236660	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	116397	usd
	us-gaap	Cost Of Revenue CostOfRevenue	233166	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-40593180	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8810533	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12859751	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9435391	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	338415	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	233919	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13840990	usd
	us-gaap	Other Expenses OtherExpenses	177554	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2279425	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2168651	usd
	us-gaap	Operating Expenses OperatingExpenses	4575123	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	144148	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	288504	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	602288	usd
	us-gaap	Cost Of Revenue CostOfRevenue	244728	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	43585	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	27751	usd
	us-gaap	Gross Profit GrossProfit	55338	usd
	us-gaap	Gross Profit GrossProfit	357560	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1184818	usd
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	985348	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2476828	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	146885	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	280700	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	290303	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	477040	usd
CY2022Q2	SGLB	Investor Public Relations InvestorPublicRelations	152300	usd
CY2021Q2	SGLB	Investor Public Relations InvestorPublicRelations	114762	usd
	SGLB	Investor Public Relations InvestorPublicRelations	246626	usd
	SGLB	Investor Public Relations InvestorPublicRelations	223103	usd
CY2022Q2	SGLB	Organizational Costs OrganizationalCosts	60817	usd
CY2021Q2	SGLB	Organizational Costs OrganizationalCosts	158529	usd
	SGLB	Organizational Costs OrganizationalCosts	119566	usd
	SGLB	Organizational Costs OrganizationalCosts	236145	usd
CY2022Q2	us-gaap	Legal Fees LegalFees	144528	usd
CY2021Q2	us-gaap	Legal Fees LegalFees	244019	usd
	us-gaap	Legal Fees LegalFees	355944	usd
	us-gaap	Legal Fees LegalFees	420866	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	303600	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	151871	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	509032	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	300096	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29861	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25783	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61445	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48814	usd
CY2022Q2	us-gaap	Other Expenses OtherExpenses	89177	usd
CY2021Q2	us-gaap	Other Expenses OtherExpenses	91198	usd
	us-gaap	Other Expenses OtherExpenses	176964	usd
	us-gaap	Operating Expenses OperatingExpenses	3950057	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2235840	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2140900	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4519785	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3592497	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1176	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	7018	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2747	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7073	usd
CY2021Q2	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	290156	usd
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	1092441	usd
	SGLB	State Incentives StateIncentives	76628	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10436	usd
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	208	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10766	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	158	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	2070	usd
CY2022Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14220	usd
CY2021Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14220	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	28440	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.100
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.168
CY2021Q2	us-gaap	Interest Expense InterestExpense	2029	usd
	us-gaap	Interest Expense InterestExpense	3389	usd
	us-gaap	Interest Expense InterestExpense	3382	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11330	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	295353	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	65220	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1096290	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2247170	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1845547	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4454565	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2496207	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2247170	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1845547	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4454565	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2496207	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	75127	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2261390	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1859767	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4483005	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2571334	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10493598	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9149328	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10856766	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2247170	usd
CY2022Q2	SGLB	Adjustments To Additional Paid In Capital Stock Options Issued For Third Party Services AdjustmentsToAdditionalPaidInCapitalStockOptionsIssuedForThirdPartyServices	11777	usd
CY2022Q2	SGLB	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	21721	usd
CY2022Q2	SGLB	Adjustments To Additional Paid In Capital Stock Options Awarded To Employees AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToEmployees	167439	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8810533	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	13419732	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1845547	usd
CY2021Q2	SGLB	Adjustments To Additional Paid In Capital Extinguishment Of Derivative Liability AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivativeLiability	4615771	usd
CY2021Q2	SGLB	Adjustments To Additional Paid In Capital Common Shares Issued For Third Party Services AdjustmentsToAdditionalPaidInCapitalCommonSharesIssuedForThirdPartyServices	24956	usd
CY2021Q2	SGLB	Adjustments To Additional Paid In Capital Stock Options Awarded To Employees AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToEmployees	116441	usd
CY2021Q2	SGLB	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	60803	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	16392156	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12859751	usd
	SGLB	Adjustments To Additional Paid In Capital Stock Options Issued For Third Party Services AdjustmentsToAdditionalPaidInCapitalStockOptionsIssuedForThirdPartyServices	23490	usd
	SGLB	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	43442	usd
	SGLB	Adjustments To Additional Paid In Capital Stock Options Awarded To Employees AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToEmployees	338415	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4454565	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	23490	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	55937	usd
	SGLB	Stock Based Compensation Directors StockBasedCompensationDirectors	43442	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	8810533	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5163732	usd
	SGLB	Stock Based Compensation Directors StockBasedCompensationDirectors	122274	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-120434	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.238
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	57888	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	73586	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2496207	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14869899	usd
	SGLB	Adjustments To Additional Paid In Capital Extinguishment Of Derivative Liability AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivativeLiability	-1092441	usd
	SGLB	Stock Issued During Period Value Common Shares Issued For Exercise Of Warrants StockIssuedDuringPeriodValueCommonSharesIssuedForExerciseOfWarrants	1136010	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	187348	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17197	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	55937	usd
	SGLB	Adjustments To Additional Paid In Capital Stock Options Awarded To Employees AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToEmployees	233919	usd
	SGLB	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	122274	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1600967	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	16392156	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4454565	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2496207	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61445	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48814	usd
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	1092441	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	338415	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	233919	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	51591	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	33958	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	186831	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-18151	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-14388	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-372188	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-14531	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4314503	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3266620	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83848	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52931	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	115197	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	55090	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-199045	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108021	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	14869899	usd
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	1600967	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1136010	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14404942	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4513548	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11030301	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11447047	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3700814	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6933499	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14731115	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y6M10D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.28
	us-gaap	Stock Issued1 StockIssued1	75108	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	SGLB	Issuance Of Securities For Services IssuanceOfSecuritiesForServices	66932	usd
	SGLB	Issuance Of Securities For Services IssuanceOfSecuritiesForServices	178209	usd
	us-gaap	Interest Paid Net InterestPaidNet	3389	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Interest Paid Net InterestPaidNet	3382	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	713010	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.15
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	21000	usd
CY2020	SGLB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P4Y1M28D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	2602143	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z4A44HZxHmE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zoxMjHzoGcyg">Reclassification</span> </b>- Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2190000	shares
CY2021Q1	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2021-05-24
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2021Q1	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2023-05-24
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	1092441	usd
CY2021	SGLB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	4.36
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M24D
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5503336	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4966350	shares
CY2021	SGLB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Grants Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm	P1Y7M17D
CY2022Q2	SGLB	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.22
CY2021Q2	SGLB	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.18
	SGLB	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.43
	SGLB	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.28
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2261390	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1859767	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4483005	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2571334	usd
CY2022Q2	SGLB	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	10498802	shares
CY2021Q2	SGLB	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	10493598	shares
	SGLB	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	10498802	shares
	SGLB	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	9149328	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zEYIRvDlwk53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zqYWTJWxv5Lh">Accounting Estimates</span></b> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	14138	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	20138	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	477802	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	698831	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	495641	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.28
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	18000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3000	usd
CY2022Q2	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	38949	usd
CY2022Q2	us-gaap	Property Subject To Or Available For Operating Lease Accumulated Depreciation PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation	2782	usd
CY2022Q2	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	36167	usd
	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P7Y
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	172863	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	202015	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	328720	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	224079	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	282083	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	283986	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	783666	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	710080	usd
CY2021	SGLB	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P4Y4M20D
CY2021	SGLB	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue	46800	usd
CY2021	SGLB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice	2.59
CY2021	SGLB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Grants Weighted Average Remaining Contractual Term Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTermExercised	P4Y1M17D
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5204	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.50
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	10755	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.49
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	37728	usd
	us-gaap	Tax Credit Carryforward Expiration Date TaxCreditCarryforwardExpirationDate	2022-12-31
	SGLB	Deferred Tax Interest Rate During Period DeferredTaxInterestRateDuringPeriod	0
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1711783	shares
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.00
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4532445	usd
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	136943	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.75
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2021Q1	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2021-05-24
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	338415	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	233919	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0095
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0165
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0019
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0032
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.064
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1395882	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.24
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M20D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	162000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.50
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1528637	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	4.05
	SGLB	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P4Y8M8D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	29245	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.54
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1528637	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M10D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3987931	shares
CY2021Q4	SGLB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	6.10
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	436963	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y10M17D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1091674	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.37
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M20D
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	990838	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M7D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1881429	shares
CY2020Q4	SGLB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	7.57
CY2021	SGLB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P2Y1M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	162150	shares
	SGLB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Weighted Average Exercise Price Warrants Forfeited Or Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled	40.00
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3825781	shares
CY2022Q2	SGLB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	4.66
	SGLB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P1Y8M8D

Files In Submission

Name	View Source	Status
0001493152-22-021416-index-headers.html	Edgar Link	pending
0001493152-22-021416-index.html	Edgar Link	pending
0001493152-22-021416.txt	Edgar Link	pending
0001493152-22-021416-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sglb-20220630.xsd	Edgar Link	pending
sglb-20220630_cal.xml	Edgar Link	unprocessable
sglb-20220630_def.xml	Edgar Link	unprocessable
sglb-20220630_lab.xml	Edgar Link	unprocessable
sglb-20220630_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTRP
NextTrip, Inc. Stock $ntrp

2022 Q3 Form 10-Q Financial Statement

#000149315222021416 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTRP NextTrip, Inc. Stock $ntrp

2022 Q3 Form 10-Q Financial Statement

#000149315222021416 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTRP
NextTrip, Inc. Stock $ntrp